EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
GAITHERSBURG, Maryland
Total Received
$2.34B
Total Awards
6
State
Maryland
Last Updated
Feb 11, 2026
Yearly Funding Trend
$2.34B24
Top 6 Awards to EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through February 11, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
CONT_AWD_HHSO100201600030C_7505_-NONE-_-NONE- EO14042 EMERGENT AV7909 ANTHRAX VACCINE | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | GAITHERSBURG, MD-06 | 2024 | $1,385,742,139 |
CONT_AWD_75A50119C00071_7505_-NONE-_-NONE- ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | GAITHERSBURG, MD-06 | 2024 | $748,857,151 |
CONT_AWD_75A50123C00037_7505_-NONE-_-NONE- THE PURPOSE OF THIS NO-COST MODIFICATION IS TO UPDATE SEVERAL ARTICLES. | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | GAITHERSBURG, MD-06 | 2024 | $118,563,679 |
CONT_AWD_HHSO100201500004C_7505_-NONE-_-NONE- ADVANCED DEVELOPMENT OF NUTHRAX (ANTHRAX VACCINE ABSORBED WITH CPG 7909) OR AV7909 | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | GAITHERSBURG, MD-06 | 2024 | $43,794,113 |
CONT_AWD_HHSO100201700001C_7505_-NONE-_-NONE- PUT A STOP TO TASKS THAT ARE NO LONGER NEEDED | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | GAITHERSBURG, MD-06 | 2024 | $32,952,759 |
CONT_AWD_W81XWH19C0193_9700_-NONE-_-NONE- ANALGESIC KETAMINE-CLINICAL TRIAL | Department of Defense Department of the Army | — | GAITHERSBURG, MD-06 | 2024 | $5,721,771 |
Top 6 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Industries
View All→1234
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY$1.46B
BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING$748.9M
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)$118.6M
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)$5.7M
Source: USAspending.gov · All Recipients · Maryland